sglt2 inhibitors with glp 1 Renal outcomes of and GLP1 agonists in clinical practice GLP-1RAs and SGLT2 Inhibitors Show

Nauck MA, Petrie JR, Sesti G, et al

The spray format may offer advantages for those who prefer sublingual delivery or have difficulty swallowing capsules

Table I [i] PIO pioglitazone, GLP-1R glucagon-like peptide 1 receptor, SGLT2 sodium-glucose co-transporters 2, TOFO tofogliflozin, SUL sulfonylurea, MET metformin, DAPA dapagliflozin, EXE exenatide, NAFLD non-alcoholic fatty liver disease, T2D type 2 diabetes, A1C glycated hemoglobin, ALT alanine aminotransferase, AST aspartate aminotransferase, -GT gamma-glutamyl transferase, MRI-PDFF MRI-proton density fat fraction, MRE-LSM MR elastography-liver stiffness, RCT randomized controlled trial, EDICT Efficacy and Durability of Initial Combination Therapy, CAP controlled attenuation parameter, LSM liver stiffness measurement, BMI body mass index

Duffield-LillicoAJReidMETurnbullBWCombsGFSlateEHFischbachLAet al